Home
Conditions
Retinitis Pigmentosa (RP)

Clinical trial condition

Retinitis Pigmentosa (RP)

Explore clinical trials studying Retinitis Pigmentosa (RP). Study availability and eligibility vary by location and protocol.

22 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Retinitis Pigmentosa (RP) trial results

Not Yet Recruiting

Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection)

NCT07282457

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

UGX202 Injection in Patients With Advanced Retinitis Pigmentosa

NCT07311863

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +6 more
Locations: Eye & ENT Hospital of Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Wide Field OCTA in Ocular Diseases

NCT07298174

Conditions: Age - Related Macular Degeneration (AMD), Best Disease, Cardiovascular Diseases, +35 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations

NCT07265895

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +9 more
Locations: IRCCS Ospedale San Raffaele Milan, Italy

View Trial Details

Not Yet Recruiting

Functional Assessments in Vision Impairment

NCT06908161

Conditions: Age Related Macular Degeneration (AMD), Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +19 more
Locations: Centre for Eye Research Australia Melbourne, Victoria, Australia

View Trial Details

Not Yet Recruiting

Retinal Investigation Using Optos OCT Device

NCT06846151

Conditions: AMD - Age-Related Macular Degeneration, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations: Not specified

View Trial Details

Completed

Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa

NCT02320812

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +6 more
Locations: The Gavin Herbert Eye Institute, Univ California Irvine Irvine, California, United States

Retina-Vitreous Associates Medical Group Los Angeles, California, United States

View Trial Details

Completed

Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT

NCT02575430

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +8 more
Locations: Wilmer Eye Institute - Johns Hopkins Hospital Baltimore, Maryland, United States

Casey Eye Institute - Marquam Hill Portland, Oregon, United States

The Hospital for Sick Children, Ophthalmology and Vision Sciences Toronto, Ontario, Canada

Montreal Children's Hospital, McGill University Health Centre Montreal, Quebec, Canada

View Trial Details

Completed

Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)

NCT01543906

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +6 more
Locations: Montreal Children's Hospital, McGill University Health Centre Montreal, Quebec, Canada

Royal Victoria Eye and Ear Hospital Dublin, Ireland

View Trial Details

Active, Not Recruiting

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

NCT06627179

Conditions: Abnormalities, Multiple, Blindness, Congenital Abnormalities, +28 more
Locations: The University of California, San Francisco San Francisco, California, United States

Bascom Palmer Eye Institute/University of Miami Miami, Florida, United States

Emory University Atlanta, Georgia, United States

Massachusetts Eye and Ear Boston, Massachusetts, United States

View all 26 locations

View Trial Details

Retinitis Pigmentosa (RP)

Retinitis Pigmentosa (RP) trial results

Related conditions